advertisement
Bell K 12
Showing records 1 to 12 | Display all abstracts from Bell K72660 A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol f
Lorenz K
Trials 2017; 18: 128
73522 Modulation of the immune system for the treatment of glaucoma
Bell K
Current Neuropharmacology 2017; 0:
72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Funke S
Expert review of proteomics 2017; 14: 311-334
73522 Modulation of the immune system for the treatment of glaucoma
Und Hohenstein-Blaul NVT
Current Neuropharmacology 2017; 0:
72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Perumal N
Expert review of proteomics 2017; 14: 311-334
72660 A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol f
Scheller Y; Bell K
Trials 2017; 18: 128
73522 Modulation of the immune system for the treatment of glaucoma
Teister J
Current Neuropharmacology 2017; 0:
72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Bell K; Pfeiffer N
Expert review of proteomics 2017; 14: 311-334
72660 A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol f
Grus F
Trials 2017; 18: 128
73522 Modulation of the immune system for the treatment of glaucoma
Grus FH
Current Neuropharmacology 2017; 0:
72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Grus FH
Expert review of proteomics 2017; 14: 311-334
72660 A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol f
Ponto KA; Bock F; Cursiefen C; Flach J; Gehring M; Peto T; Silva R; Tal Y; Pfeiffer N
Trials 2017; 18: 128
